Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J’s role in the field after it acquired another experimental prostate-cancer treatment four years ago that has become a leading brand.
Read More...Cancer News
- Bladder Cancer (65)
- Brain Tumor Cancer (38)
- Breast Cancer (8038)
- Cancer Bulletins (543)
- Cancer Clinical Trials (5107)
- Cancer Treatment (1239)
- Colon Rectal Cancer (5960)
- General Cancer (17318)
- Leukemia Lymphoma Cancer (10605)
- Lung Mesothelioma Asbestos (4905)
- Ovarian Cervical Uterine Cancer (1176)
- Pancreatic Cancer (56)
- Prostate Cancer (6907)
- Skin Cancer (6052)
- Uncategorized (53)
-
Cancer News Topics
- Aspirin may fight cancer by slowing DNA damage
- Nanog protein promotes growth of head and neck cancer
- New resistance mechanism to chemotherapy in breast and ovarian cancer
- Chemical probe confirms that body makes its own rotten egg gas, H2S, to benefit health
- Reader Submitted: Terri Brodeur Breast Cancer Foundation Seeks Two Team Lead Volunteers
- Canada-U.S. team develops promising ‘sharp-shooter’ drug aimed at several cancers
- Battle with Mesothelioma Turned Janelle Bedel into Unlikely Hero as ‘Wonder Woman’
- Medical card holders face GP cancer care costs
- Nebraska Company Faces Large Fine for Illegal Asbestos Disposal
- Immune-boosting Antibodies May Help in Lung Cancer Treatment
- Owner of Former Nestle Plant Pled Guilty to Illegally Removing Asbestos
- After Asbestos Remediation, Pieces of Former Casady School in Des Moines Preserved By Habitat Restore
- Asbestos Problems at Hawaii Low-Income Housing Complex
- Executive Director of Hawaii Housing Non-Profit Fired Over Raising Concerns Over Asbestos
- Crizotinib Improves Progression-Free Survival in Some Patients with Advanced Lung Cancer
- News From Frontiers In Microbiology, Oncology, Neuroscience
- Woman Forced To Quit Job After Shaving Her Head For Sister
- Local woman starts cancer support group
- NIH scientists find promising biomarker for predicting HPV-related oropharynx cancer
- Reforms speed initiation of NCI-sponsored clinical trials
- Low-Risk Prostate Cancer, Observation Is Safe
- Mathematical Models Being Used In The Fight Against Cancer
- In The Spread Of Cancer, A Developmental Protein Plays A Role
- Process Of Metastasis Explained By ‘Chase And Run’ Cell Movement Mechanism
- Previously Unknown Surveillance Mechanism Used By Cells To Monitor Oxidatively Damaged DNA